Analysts expect revenue increase Carl Zeiss Meditec

Next Monday the German company Carl Zeiss Meditec will publish its past quarters results. For this year Carl Zeiss Meditec's revenue will be around 1,61 billion euros. This is according to the average of the analysts' estimates. This is rather significant more than 2018's revenue of 1,46 billion euros.

Historical revenues and results Carl Zeiss Meditec plus estimates 2020

The analysts expect for 2020 a net profit of 206 million euros. The majority of the analysts expects for this year a profit per share of 2,31 euros. With this the price/earnings-ratio is an extreme 50,39.

Per share the analysts anticipate on a dividend of 0,77 cents per share. Thus the dividend yield equals 0,66 percent. The average dividend yield of the pharmaceutical companies equals a relatively high 1,99554907052689 percent.

Latest estimates around 97 euros

The most recent recommendations for the pharmaceutical company are from Hauck & Aufhauser, Berenberg and Kepler Capital Markets.

Based on the current number of shares Carl Zeiss Meditec's market capitalization equals 10,41 billion euros. The Carl Zeiss Meditec stock was the past 12 months quite unstable. Since last February the stock is even 43 percent higher. This year the stock price moved between 71 and 122 euro. Since 2008 the stock price is almost 837 percent higher.

Price data Carl Zeiss Meditec 2007-2020

Click here for dividend . At 11.50 the stock trades 0,95 percent lower at 116,4 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.